Editorial
doi: 10.2165/11535680-000000000-00000.
Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally
- PMID: 20402539
- DOI: 10.2165/11535680-000000000-00000
Item in Clipboard
Editorial
Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally
Pharmacoeconomics.
2010.
No abstract available
Similar articles
-
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.Pharmacoeconomics. 2010;28(5):351-62. doi: 10.2165/11532160-000000000-00000. Pharmacoeconomics. 2010. PMID: 20131924 Review.
-
Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck.Health Technol Assess. 2009 Jun;13 Suppl 1:49-54. doi: 10.3310/hta13suppl1/08. Health Technol Assess. 2009. PMID: 19567214
-
Alitretinoin for the treatment of severe chronic hand eczema.Health Technol Assess. 2010 May;14 Suppl 1:39-46. doi: 10.3310/hta14Suppl1/06. Health Technol Assess. 2010. PMID: 20507802 Review.
-
[Off-label use of alitretinoin].Hautarzt. 2013 Oct;64(10):748-51. doi: 10.1007/s00105-013-2593-2. Hautarzt. 2013. PMID: 24150823 Review. German.
-
Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.Clin Drug Investig. 2011 Oct 1;31(10):717-26. doi: 10.2165/11588980-000000000-00000. Clin Drug Investig. 2011. PMID: 21744880
Cited by
-
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal.Pharmacoeconomics. 2014 Dec;32(12):1171-83. doi: 10.1007/s40273-014-0189-z. Pharmacoeconomics. 2014. PMID: 25059204 Free PMC article.
-
Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal.Pharmacoeconomics. 2013 Jul;31(7):551-62. doi: 10.1007/s40273-013-0051-8. Pharmacoeconomics. 2013. PMID: 23620211 Review.
-
Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Pharmacoeconomics. 2012. PMID: 22950547 Review.
-
Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.Pharmacoeconomics. 2011 Nov;29(11):951-61. doi: 10.2165/11589310-000000000-00000. Pharmacoeconomics. 2011. PMID: 21854080 Review.
-
Aripiprazole for the treatment and prevention of acute manic and mixed episodes in bipolar I disorder in children and adolescents: a NICE single technology appraisal.Pharmacoeconomics. 2013 Nov;31(11):981-90. doi: 10.1007/s40273-013-0091-0. Pharmacoeconomics. 2013. PMID: 24092620 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
